只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 2026-07-02 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah Officer · Chief Medical Officer | 卖出（S） | 4,007 | US$37.56 | US$150,502.92 | 84,645 | SEC |
| 2026-04-24 2026-04-24 | TORO TORO CORP. | Panagiotidis Petros Panagiotis Director,Officer · Chief Executive Officer | 买入（P） | 67,407 | US$6.79 | US$457,693.53 | 20,822,206 | SEC |
| 2026-04-23 2026-04-24 | TORO TORO CORP. | Panagiotidis Petros Panagiotis Director,Officer · Chief Executive Officer | 买入（P） | 265,836 | US$6.52 | US$173.33万 | 20,754,799 | SEC |
| 2026-04-22 2026-04-24 | TORO TORO CORP. | Panagiotidis Petros Panagiotis Director,Officer · Chief Executive Officer | 买入（P） | 516,738 | US$5.04 | US$260.44万 | 19,022,973 | SEC |
| 2026-04-22 2026-04-24 | TORO TORO CORP. | Panagiotidis Petros Panagiotis Director,Officer · Chief Executive Officer | 买入（P） | 1,465,990 | US$6.45 | US$945.56万 | 20,488,963 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Goff Brian Director,Officer · Chief Executive Officer | 卖出（S） | 12,472 | US$34.71 | US$432,903.12 | 177,604 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Goff Brian Director,Officer · Chief Executive Officer | 卖出（S） | 6,596 | US$34.71 | US$228,947.16 | 184,508 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan Officer · Chief Corp Dev & Strategy | 卖出（S） | 2,959 | US$34.71 | US$102,706.89 | 10,282 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta Officer · Chief Commercial Officer | 卖出（S） | 3,262 | US$34.71 | US$113,224.02 | 46,829 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Jones Cecilia Officer · Chief Financial Officer | 卖出（S） | 3,141 | US$34.71 | US$109,024.11 | 54,998 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah Officer · Chief Medical Officer | 卖出（S） | 2,940 | US$34.71 | US$102,047.40 | 80,277 | SEC |
| 2026-04-02 2026-04-06 | AGIO AGIOS PHARMACEUTICALS, INC. | Burns James William Officer · Chief Legal Officer | 卖出（S） | 3,280 | US$34.71 | US$113,848.80 | 49,306 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| AGIO | 308,821.2994 | 488 | 799,897.371 | 38.61% | B, Q, N |